NAD+ Dosage IV Therapy: Expert Guide to Protocols
TL;DR: NAD+ dosage for IV therapy typically ranges from 250mg to 1000mg per session, with most protocols starting at 500mg. Treatment frequency and dosage are personalized based on your health goals, tolerance, and physician assessment. Research from clinical applications shows NAD+ supplementation may support cellular energy production.
Medically reviewed by the Vea Health Clinical Team
NAD+ dosage IV therapy has become a cornerstone of physician-led wellness protocols for adults seeking to support cellular health and energy metabolism. But determining the right dose isn't one-size-fits-all.
Your protocol depends on multiple factors. These include your baseline health status, specific wellness goals, and how your body responds to initial sessions.
What Is NAD+ IV Therapy?
NAD+ IV therapy delivers nicotinamide adenine dinucleotide (a molecule your cells use for energy) directly into your bloodstream through an intravenous infusion. This delivery method bypasses the digestive system, allowing for higher concentrations to reach your cells compared to oral supplementation. Patients have reported improvements in mental clarity, physical energy, and overall vitality within hours to days of their first session.
The therapy gained attention in integrative medicine circles as research expanded on NAD+'s role in cellular metabolism. Your body naturally produces NAD+, but levels decline with age. By age 50, many adults have roughly half the NAD+ they had in their youth.
IV administration allows physicians to deliver therapeutic doses that would be difficult to achieve through diet or oral supplements alone. The infusion typically takes 2 to 4 hours, depending on your dosage and tolerance.
How Much NAD+ Is Used in IV Therapy?
Standard NAD+ IV therapy protocols range from 250mg to 1000mg per session, with 500mg being the most common starting point for adults new to the therapy. Dosing decisions are made by your physician based on your health history, current medications, and treatment objectives. Many practices use a gradual titration approach, starting lower and adjusting upward based on your response.
Lower doses (250-500mg) are often used for maintenance protocols or for patients new to NAD+ therapy. These sessions typically take 2 to 3 hours to infuse. Mid-range doses (500-750mg) represent the sweet spot for many patients seeking cellular support and are commonly used in ongoing wellness protocols. Higher doses (750-1000mg) may be recommended for more intensive protocols, though these require longer infusion times and closer monitoring.
The infusion rate matters as much as the total dose. Too rapid administration can cause temporary discomfort, including flushing, chest tightness, or nausea. Your clinician will adjust the drip rate based on your real-time feedback. Most patients tolerate the therapy well once the optimal rate is established.
Frequency varies widely based on goals. Some patients receive weekly infusions for 4 to 6 weeks, then transition to monthly maintenance. Others opt for monthly sessions from the start. There's no universal schedule. Your physician will create a timeline that aligns with your objectives and response.
What Does Research Show About NAD+ Dosing?
Clinical research on NADH supplementation has primarily focused on neurological applications, with a 1989 study by Birkmayer & Birkmayer documenting the use of NADH in 34 Parkinson's patients. According to that research, 61.7% of patients showed improvements exceeding 30% in disability scores after treatment. A subsequent double-blind study by Dizdar et al. in 1994 further examined NADH administration in Parkinson's patients, though it emphasized the need for controlled trials to verify clinical effects.
These studies used NADH (the reduced form of NAD+) rather than NAD+ itself, and they focused on oral or intramuscular administration for a specific neurological condition. The dosing in those trials differed significantly from current IV NAD+ protocols used in wellness medicine. Still, they established that NAD-related molecules could be administered safely and that patients may experience measurable physiological changes.
Modern IV NAD+ therapy evolved from these early investigations but serves different purposes. Today's protocols focus on cellular energy support, metabolic function, and age-related decline rather than disease treatment. The evidence base continues to expand as more clinicians document patient outcomes and researchers investigate NAD+'s role in cellular health.
Factors That Influence Your NAD+ Protocol
Your personalized NAD+ dosage isn't pulled from a chart. Several variables shape your physician's recommendations.
Age and baseline NAD+ levels play a significant role. Older adults often start with higher doses because their natural NAD+ production has declined more substantially. Some practices offer NAD+ blood testing to establish a baseline, though this isn't universally available.
Your wellness goals directly impact protocol design. Someone seeking cognitive support might follow a different schedule than someone focused on physical recovery or metabolic optimization. The dosing strategy shifts based on which cellular systems you're targeting.
Previous experience with NAD+ therapy matters considerably. First-time patients typically start at lower doses to assess tolerance. Those who've completed multiple sessions often move to higher doses as their bodies adapt. This gradual approach minimizes discomfort and maximizes your likelihood of completing the full infusion.
Current health status and medications influence both dose and frequency. Your physician will review your complete medical history before recommending a protocol. Certain conditions or medications may warrant dose adjustments or additional monitoring during your sessions.
Tolerance and side effect profile guide real-time adjustments. Some patients sail through 1000mg infusions with zero discomfort. Others need to start at 250mg and increase slowly. Neither response is better or worse. It's simply individual variation.
What to Expect During Your NAD+ IV Therapy Session
Most patients describe the infusion experience as relaxing once the drip rate is properly calibrated to their tolerance. You'll be seated in a comfortable chair for the duration of your session, which typically lasts 2 to 4 hours depending on your dose. Many patients bring a book, laptop, or simply rest during the infusion.
The first 15 to 30 minutes are critical for establishing your optimal infusion rate. Your clinician will start slowly and monitor for any discomfort. Some patients experience mild sensations including warmth in the chest, slight nausea, or facial flushing. These effects are temporary and usually resolve when the drip rate is slowed.
As your body adjusts to the therapy over multiple sessions, you'll likely tolerate faster infusion rates. This means shorter session times for the same dose. Patients who initially needed 4 hours for a 500mg infusion often complete it in 2 hours by their third or fourth visit.
After the infusion, many patients report feeling energized or mentally sharp within hours. Others notice subtle improvements over the following days. Response timing varies. Some people feel effects immediately, while others require several sessions before noticing changes.
At Vea Health, our physician-led team designs anti-aging protocols that may include NAD+ IV therapy as part of a comprehensive approach to cellular health. We adjust dosing based on your individual response and ongoing assessment.
Ready to explore whether NAD+ IV therapy fits your wellness goals?
START YOUR CONSULTATION with our medical team to discuss your personalized protocol options.
Frequently Asked Questions
How often should I receive NAD+ IV therapy?
Frequency depends on your goals and your physician's recommendations. Many patients start with weekly sessions for 4 to 6 weeks, then transition to monthly maintenance infusions. Some opt for monthly sessions from the beginning. Your response to initial treatments will guide the schedule your clinician recommends.
Is 500mg or 1000mg of NAD+ better for IV therapy?
Neither dose is inherently superior. The optimal amount depends on your tolerance, experience with NAD+ therapy, and wellness objectives. First-time patients typically start with 250-500mg to establish tolerance. Your physician may increase the dose in subsequent sessions based on your response and goals.
How long does it take to feel effects from NAD+ IV therapy?
Response timing varies significantly between individuals. Some patients report increased mental clarity or energy within hours of their first infusion. Others notice gradual improvements over several sessions. Clinical experience shows most patients begin recognizing changes within the first 2 to 4 weeks of consistent treatment.
Can NAD+ IV therapy dosage be too high?
Excessively high doses or rapid infusion rates can cause temporary discomfort including nausea, chest tightness, and cramping. These effects resolve when the infusion is slowed or stopped. Your clinician will monitor your tolerance throughout the session and adjust accordingly. Starting with lower doses and titrating upward minimizes the risk of uncomfortable side effects.
Does NAD+ IV therapy require any special preparation?
Most clinicians recommend being well-hydrated before your session and eating a light meal 1 to 2 hours beforehand. Arriving hydrated makes IV placement easier and may improve your overall tolerance. Some practices suggest avoiding alcohol for 24 hours before treatment, though specific preparation instructions will come from your physician based on your protocol.
References
Birkmayer W & Birkmayer G. Nicotinamidadenindinucleotide (NADH): the new approach in the therapy of Parkinson's disease. Annals of clinical and laboratory science (1989). PMID: 2644889
Dizdar N et al. Treatment of Parkinson's disease with NADH. Acta neurologica Scandinavica (1994). PMID: 7887134
Learn more about your options:
Source Studies:
Randomized phase III trial of amrubicin versus topotecan as second-line treatmen... — Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2014)
Treatment of Parkinson's disease with NADH. — Acta neurologica Scandinavica (1994)
Enhanced rate of ethanol elimination from blood after intravenous administration... — Alcohol and alcoholism (Oxford, Oxfordshire) (2006)
Compounded medications are not approved by the FDA and have not been reviewed for safety, effectiveness, or quality.
Treatments are prescribed at provider discretion. Individual results may vary.